Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 57 out of 100. Disparities

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

Dementia poses a significant global health challenge for both clinicians and patients, impacting millions of individuals worldwide, yet its early diagnosis remains underexplored. The current technology-driven dementia care solutions are revolutionising this landscape with state-of-the-art methodologies (such as Artificial Intelligence (AI)); however, due to its black-box nature, there is a need for Explainable AI (xAI) to help build trust and confidence among end-users, making it more suitable for real-world healthcare applications. This scoping review aims to provide a comprehensive overview of the current xAI usage in this field by synthesising data from studies published since 2014. Through a structured literature extraction process following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Review (PRISMA-ScR) guidelines, a total of 415 scientific papers were screened, resulting in 70 eligible articles for an in-depth analysis regarding dementia detection and prognosis using xAI techniques. Most studies relied on public datasets (e.g. ADNI) without clinical validation. A detailed thematic analysis presents the findings of this review, which identifies the most widely used tools, approaches, types of data, and the key limitations/challenges in implementing xAI for dementia detection and prognosis used in the latest research. These findings provide valuable insights and direction for future research in this field by highlighting the underutilization of multimodal data integration, persistent inconsistencies in feature importance rankings across methods, and the imprecision of visual explanations.

What this study adds

Evidence grade: High

This is a pooled review of 415 participants. This scoping review found that most studies using explainable AI for dementia detection and prognosis relied on public datasets without clinical validation. It addresses diagnostic technology, not treating, curing, or preventing the disease.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Nguyen, P. A., Din, F. U., Krug, M., & Jones, R. (2026). Use of explainable AI (xAI) in dementia detection and prognosis: a scoping review. BMC Medical Informatics and Decision Making. https://doi.org/10.1186/s12911-025-03279-y

Vancouver

Nguyen PA, Din FU, Krug M, Jones R. Use of explainable AI (xAI) in dementia detection and prognosis: a scoping review. BMC Medical Informatics and Decision Making. 2026. doi:10.1186/s12911-025-03279-y. PMID: 41546043.

BibTeX

@article{nguyen2026-41546043,
  author  = {Nguyen, Phuong Anh and Din, Fareed Ud and Krug, Matthew and Jones, Rikki},
  title   = {{Use of explainable AI (xAI) in dementia detection and prognosis: a scoping review}},
  journal = {BMC Medical Informatics and Decision Making},
  year    = {2026},
  doi     = {10.1186/s12911-025-03279-y},
  pmid    = {41546043},
  url     = {https://doi.org/10.1186/s12911-025-03279-y}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This scoping review found that most studies using explainable AI for dementia detection and prognosis relied on public datasets without clinical validation. It addresses diagnostic technology, not treating, curing, or preventing the disease.

Study details

How this study scored 57/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 12 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 4 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 1 of 4; Institution's track record 0 of 3; Multicenter collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 57 of 100.57 of 100 points earned43 not earned

Published in a peer-reviewed journal, and it is a meta-analysis pooling many studies. Scored zero for effect reported because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (BMC Medical Informatics and Decision Making)
Journal's citation record 1 / 4 BMC Medical Informatics and Decision Making: journal h-index 145 (OpenAlex, 2026-10-29)
Study design 12 / 12 A meta-analysis pooling many studies
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 2 / 4 415 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 A review of other studies — randomization is not credited here
Times cited 1 / 7 Cited 4 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 2.0 citations a year over 2 year(s) since 2026
Impact for its field and year 4 / 6 Cited 14.9× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Rikki Jones: h-index 10 (OpenAlex, whole career)
Institution's track record 0 / 3 University of New England: institution h-index 358 (OpenAlex)
Multicenter collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41546043)
Free to read 2 / 2 Free to read
Total 57 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Disparities from nearby years

Also tagged “machine”

834 studies in the library carry the topic tag “machine”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 834 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Disparities

See all studies in Disparities →